Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

Blood (2019) 134 (Supplement_1): 225.

https://doi.org/10.1182/blood-2019-125009

Published: 2019

Journal Articles

Systematic Literature Review of the Economic Burden and Cost of Illness in Patients with Myelofibrosis

Derek Tang, PhD BSPharm, Ankush Taneja, Preety Rajora, Renu Patel

Blood (2019) 134 (Supplement_1): 2184.

https://doi.org/10.1182/blood-2019-122919

Published: 2019

Journal Articles

Overall Survival in Patients with Myelofibrosis Who Have Discontinued Ruxolitinib: A Literature Review

Derek Tang, PhD BSPharm, Ankush Taneja, Preety Rajora, Indeg Sly, Niall James Davison

Blood (2019) 134 (Supplement_1): 3457.

https://doi.org/10.1182/blood-2019-122904

Published: 2019

Journal Articles

The Necessary for Long-Term Follow-up of Mutated Genes and Clonal Evolutions in Multiple Myeloma Combined with cfDNA Assay

Yuko Mishima, MD PhD, Yuji Mishima, PhD, Masahiro Yokoyama, MD, Noriko Nishimura, MD PhD, Yoshiharu Kusano, MD, Norihito Inoue, MD, Hideki Uryu, MD, Takanori Fukuta, MD, Yuko Shirouchi, MD, Kiyohiko Hatake, MD PhD, Yasuhito Terui, MD PhD

Blood (2019) 134 (Supplement_1): 5515.

https://doi.org/10.1182/blood-2019-122977

Published: 2019

Journal Articles

Genetic Profiling and Novel Recurrent Chromosomal Alterations in Patients with Light Chain Amyloidosis

Blood (2018) 132 (Supplement 1): 4488.

https://doi.org/10.1182/blood-2018-99-114543

Published: 2018

Journal Articles

Antimyeloma Effect of the Simultaneous Inhibition of MCL-1 (with S63845) and BCL-2 (with Venetoclax) in the Presence of the Microenvironment

Esperanza M Algarín, MSc, Andrea Díaz-Tejedor, Pedro Mogollón, Susana Hernández-García, Luis Corchete, Laura San-Segundo, Montserrat Martín-Sánchez, Lorena González-Méndez, Marie Schoumacher, Sébastien Banquet, Laurence Kraus-Berthier, Ioana Kloos, Ensar Halilovic, Heiko Maacke, Norma C. Gutierrez, MD PhD, Maria-Victoria Mateos, MD PhD, Teresa Paíno, Mercedes Garayoa, Enrique M. Ocio, MD

Blood (2018) 132 (Supplement 1): 954.

https://doi.org/10.1182/blood-2018-99-116075

Published: 2018

Journal Articles

A Systems Biology Approach to Identify Mechanisms of Therapy Resistance in Multiple Myeloma

Rafael Renatino Canevarolo, PhD, Praneeth Reddy Sudalagunta, PhD, Maria D Coelho Siqueira Silva, MSc, Mark B. Meads, PhD, Priscilla Granados, Anders Berglund, Amit Kulkarni, PhD, Hongyue Dai, PhD, William S. Dalton, PhDMD, Ion Petre, PhD, Kenneth H. Shain, MD PhD, Ariosto Siqueira Silva, PhD

Blood (2018) 132 (Supplement 1): 3266.

https://doi.org/10.1182/blood-2018-99-118784

Published: 2018

Journal Articles

Cy7-Tocilizumab/Fab(Tocilizumab): Near Infrared Fluorescence In Vivo Imaging of Multiple Myeloma

Ximena Camacho, MSc, Carolina Perroni, Lic, Mara de Souza Junqueira, Marcelo Fernandez, Roger Chammas, Carlos Buchpiguel, Juan Pablo Gambini, Pablo Cabral, Eloisa Riva, MD

Blood (2018) 132 (Supplement 1): 5621.

https://doi.org/10.1182/blood-2018-99-114186

Published: 2018

Journal Articles

Delphi, a Data Warehouse to Discover Associations between Variables in Clinical Trials: Application to the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial

Blood (2017) 130 (Supplement 1): 3451.

https://doi.org/10.1182/blood.V130.Suppl_1.3451.3451

Published: 2017

Journal Articles

Features of the Immunophenotype of Tumor Plasmocytes in the Bone Marrow and Peripheral Blood for Multiple Myeloma Complicated By Plasmacytomas

Kirill Belousov, Anatoly Golenkov, MD, Tatiana Mitina, Yulia Chuksina, Elena Trifonova, MD PhD, Elena Kataeva, MD, Lyudmila Vysotskaya, Yulia Chernykh, Sergei Zakharov, Aleksandr Mitin, Sergei Shevelev, Yulia Sverkunova, Elena Klinushkina

Blood (2017) 130 (Supplement 1): 5334.

https://doi.org/10.1182/blood.V130.Suppl_1.5334.5334

Published: 2017

Journal Articles

Identification of Myeloperoxidase As a Leukemia-Associated Antigen and Therapeutic Target for Acute Myeloid Leukemia

Eran Tallis, Sijie Lu, PhD, Xiaoling Ding, Dan Li, PhD, Kathryn Ruisaard, M. James You, MD PhD, Lisa St. John, Gheath Alatrash, DO, PhD, Qing Ma, PhD, Jeffrey J. Molldrem, MD

Blood (2017) 130 (Supplement 1): 4460.

https://doi.org/10.1182/blood.V130.Suppl_1.4460.4460

Published: 2017

Journal Articles

Long-Term Follow-up of a Prospective Clinical Trial of Carfilzomib, Rituximab and Dexamethasone (CaRD) in Waldenstrom's Macroglobulinemia

Kirsten Meid, MPH, Toni Dubeau, NP, Patricia Severns, NP, Joshua Gustine, Irene M Ghobrial, MD, Jorge J. Castillo, MD, Steven P Treon, MDPhDFRCP

Blood (2017) 130 (Supplement 1): 2772.

https://doi.org/10.1182/blood.V130.Suppl_1.2772.2772

Published: 2017

Journal Articles

Molecular Subtypes of Plasma Cell Neoplasms with Circulating Neoplastic Plasma Cells

Anwar Rjoop, Soumya Pandey, Giovani Insuasti, MD, Rodolfo Lobo Henrich, MD, Carolina D. Schinke, MD, Maurizio Zangari, MD, Frits van Rhee, MD PhD, Gareth J. Morgan, MD PhD, Faith E Davies, MD, Daisy Alapat, MD

Blood (2017) 130 (Supplement 1): 4387.

https://doi.org/10.1182/blood.V130.Suppl_1.4387.4387

Published: 2017

Journal Articles

Increased Frequencies of PD-1+ CD8+ Marrow-Infiltrating Lymphocytes Associated with Highly Clonal T-Lymphocyte Expansions in Relapsed and Refractory AML Patients but Not Healthy Adults

Meghali Goswami, Karolyn Oetjen, MD PhD, Matthew P. Mulé, BS, Sheenu Sheela, MBBS, Hong Yuen Wong, PhD, Qingguo Liu, MD, Katherine R. Calvo, MD PhD, Catherine E. Lai, MD, Christopher S. Hourigan, MD PhD

Blood (2016) 128 (22): 1644.

https://doi.org/10.1182/blood.V128.22.1644.1644

Published: 2016

Journal Articles

Potential for Dendritic Cell Stimulated De Novo Anti-Leukaemia CD4 T Cell Response in the Bone Marrow Tumour Microenvironment during Induction Chemotherapy

Kate L E Phillips, PhD, Joanne E Dean, BSc, Brian F Flanagan, PhD, Steve E Christmas, DPhil, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2016) 128 (22): 2524.

https://doi.org/10.1182/blood.V128.22.2524.2524

Published: 2016

Journal Articles

Harnessing the Tumor Microenvironment for the Treatment of Double Hit Lymphoma

Chen Lossos, Yunpeng Liu, Amanda L. Christie, BS, Michael T. Hemann, PhD, David M Weinstock

Blood (2016) 128 (22): 47.

https://doi.org/10.1182/blood.V128.22.47.47

Published: 2016

Journal Articles

Addition of Fludarabine to Cyclophosphamide Lymphodepletion Improves In Vivo Expansion of CD19 Chimeric Antigen Receptor-Modified T Cells and Clinical Outcome in Adults with B Cell Acute Lymphoblastic Leukemia

Cameron J Turtle, MBBS, PhD, Laila-Aicha Hanafi, PhD, Carolina Berger, MD, Daniel Sommermeyer, PhD, Barbara Pender, MS, Emily M Robinson, BS, Katherine Melville, Tanya M Budiarto, BSc, Natalia N Steevens, Colette Chaney, RN, Sindhu Cherian, MD, Brent L Wood, MD PhD, Lorinda Soma, MD, Xueyan Chen, MD PhD, Shelly Heimfeld, PhD, Michael C Jensen, MD, Stanley R. Riddell, MD, David G Maloney, MD PhD

Blood (2015) 126 (23): 3773.

https://doi.org/10.1182/blood.V126.23.3773.3773

Published: 2015

Journal Articles

Integrated Immunological Analysis of the Bone Marrow Tumor Microenvironment in Myeloproliferative Neoplasms to Determine Potential Efficacy of Immune Checkpoint Blockade

Robert Orlowski, MD, Alexander Huang, Mercy Gohil, James Mangan, MD PhD, Marissa Vignali, PhD, Ryan O Emerson, PhD, Harlan Robins, PhD, Erik Yusko, PhD, Martha S Jordan, PhD, Martin Carroll, MD, D. Gary Gilliland, MD PhD, Elizabeth O Hexner, MD

Blood (2015) 126 (23): 2766.

https://doi.org/10.1182/blood.V126.23.2766.2766

Published: 2015

Journal Articles

A Next Generation Sequencing-Based Approach to Detect Gene Mutations, Copy Number Changes and IGH Translocations in Multiple Myeloma

Niccolo Bolli, MD PhD, Graham R Bignell, PhD, Peter Ganly, BMBCh, PhD, Elli Papaemmanuil, PhD, Herve Avet-Loiseau, Adam Sperling, MD PhD, Stephane Minvielle, Peter J Campbell, PhD, Nikhil C. Munshi, MD

Blood (2014) 124 (21): 3364.

https://doi.org/10.1182/blood.V124.21.3364.3364

Published: 2014

Journal Articles

Targeting PYK2 Mediates Microenvironment-Specific Myeloma Cell Death

Kenneth H. Shain, MD PhD, Mark B Meads, PhD, Bin Fang, PhD, Linda Mathews, Jennifer Gemmer, Liang Nong, MD, Ismael Rosado-Lopez, BS, Jennifer E. Ring, Robert MacLeod, PhD, Lori Hazlehurst, PhD, Conor Lynch, PhD, Jonathan A. Pachter, PhD, William Matsui, MD, John Koomen, PhD, Tuan Nguyen

Blood (2014) 124 (21): 2081.

https://doi.org/10.1182/blood.V124.21.2081.2081

Published: 2014

NARROW

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

Systematic Literature Review of the Economic Burden and Cost of Illness in Patients with Myelofibrosis

Overall Survival in Patients with Myelofibrosis Who Have Discontinued Ruxolitinib: A Literature Review

The Necessary for Long-Term Follow-up of Mutated Genes and Clonal Evolutions in Multiple Myeloma Combined with cfDNA Assay

Genetic Profiling and Novel Recurrent Chromosomal Alterations in Patients with Light Chain Amyloidosis

Antimyeloma Effect of the Simultaneous Inhibition of MCL-1 (with S63845) and BCL-2 (with Venetoclax) in the Presence of the Microenvironment

A Systems Biology Approach to Identify Mechanisms of Therapy Resistance in Multiple Myeloma

Cy7-Tocilizumab/Fab(Tocilizumab): Near Infrared Fluorescence In Vivo Imaging of Multiple Myeloma

Delphi, a Data Warehouse to Discover Associations between Variables in Clinical Trials: Application to the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial

Features of the Immunophenotype of Tumor Plasmocytes in the Bone Marrow and Peripheral Blood for Multiple Myeloma Complicated By Plasmacytomas

Identification of Myeloperoxidase As a Leukemia-Associated Antigen and Therapeutic Target for Acute Myeloid Leukemia

Long-Term Follow-up of a Prospective Clinical Trial of Carfilzomib, Rituximab and Dexamethasone (CaRD) in Waldenstrom's Macroglobulinemia

Molecular Subtypes of Plasma Cell Neoplasms with Circulating Neoplastic Plasma Cells

Increased Frequencies of PD-1+ CD8+ Marrow-Infiltrating Lymphocytes Associated with Highly Clonal T-Lymphocyte Expansions in Relapsed and Refractory AML Patients but Not Healthy Adults

Potential for Dendritic Cell Stimulated De Novo Anti-Leukaemia CD4 T Cell Response in the Bone Marrow Tumour Microenvironment during Induction Chemotherapy

Harnessing the Tumor Microenvironment for the Treatment of Double Hit Lymphoma

Addition of Fludarabine to Cyclophosphamide Lymphodepletion Improves In Vivo Expansion of CD19 Chimeric Antigen Receptor-Modified T Cells and Clinical Outcome in Adults with B Cell Acute Lymphoblastic Leukemia

Integrated Immunological Analysis of the Bone Marrow Tumor Microenvironment in Myeloproliferative Neoplasms to Determine Potential Efficacy of Immune Checkpoint Blockade

A Next Generation Sequencing-Based Approach to Detect Gene Mutations, Copy Number Changes and IGH Translocations in Multiple Myeloma

Targeting PYK2 Mediates Microenvironment-Specific Myeloma Cell Death

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only